Opaleye Management Inc. - Nov 10, 2023 Form 4 Insider Report for Tracon Pharmaceuticals, Inc. (TCON)

Role
10%+ Owner
Signature
Opaleye Management Inc., By: /s/ James Silverman, President
Stock symbol
TCON
Transactions as of
Nov 10, 2023
Transactions value $
-$1,401,571
Form type
4
Date filed
11/14/2023, 04:05 PM
Previous filing
Sep 20, 2023
Next filing
Mar 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCON Common Stock, par value $0.001 per share Sale -$1.27M -4.32M -100% $0.29 0 Nov 10, 2023 By Opaleye, L.P. F1, F3
transaction TCON Common Stock, par value $0.001 per share Sale -$129K -440K -100% $0.29 0 Nov 10, 2023 By Managed account F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TCON Prefunded Warrants 1.67M Nov 10, 2023 Common Stock 1.67M $0.01 By Opaleye,L.P. F1, F4
holding TCON Prefunded Warrants 1.36M Nov 10, 2023 Common Stock 1.36M $0.01 By Opaleye,L.P. F1, F4
holding TCON Prefunded Warrants 2.21M Nov 10, 2023 Common Stock 2.21M $0.01 By Opaleye, L.P. F1, F4
holding TCON Prefunded Warrants 2.01M Nov 10, 2023 Common Stock 2.01M $0.01 By Opaleye, L.P. F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Opaleye Management Inc. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Represents securities owned directly by Opaleye, L.P. (The "Fund"). As the investment manager of the Fund.
F2 Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to own the securities owned directly by the Managed Account beneficially.
F3 This transaction was executed in multiple trades at prices ranging from $0.21 to $0.375; the price reported above reflects the weighted average purchase price. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased.
F4 The warrants may not be exercised to the extent that such exercise would cause the reporting person and its affiliates to beneficially own more than 19.99% of the Issuer's then outstanding common stock.